CRYAB and myeloid sarcoma: Since other small HSP such as HSPB1 and HSPB8 have previously been reported to share TLR agonist activity with HSPB5 [16–18], the present study addressed the question whether small HSPs other than HSPB5 display similar expression profiles during lesional development in MS.